These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17980664)

  • 1. Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South Africa.
    Banaiee N; January V; Barthus C; Lambrick M; Roditi D; Behr MA; Jacobs WR; Steyn LM
    Tuberculosis (Edinb); 2008 Jan; 88(1):64-8. PubMed ID: 17980664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico.
    Banaiee N; Bobadilla-Del-Valle M; Bardarov S; Riska PF; Small PM; Ponce-De-Leon A; Jacobs WR; Hatfull GF; Sifuentes-Osornio J
    J Clin Microbiol; 2001 Nov; 39(11):3883-8. PubMed ID: 11682502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages.
    Banaiee N; Bobadilla-Del-Valle M; Riska PF; Bardarov S; Small PM; Ponce-de-Leon A; Jacobs WR; Hatfull GF; Sifuentes-Osornio J
    J Med Microbiol; 2003 Jul; 52(Pt 7):557-561. PubMed ID: 12808076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates.
    Hazbón MH; Guarín N; Ferro BE; Rodríguez AL; Labrada LA; Tovar R; Riska PF; Jacobs WR
    J Clin Microbiol; 2003 Oct; 41(10):4865-9. PubMed ID: 14532245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Bergmann JS; Woods GL
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):153-6. PubMed ID: 9294706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs.
    Rüsch-Gerdes S; Domehl C; Nardi G; Gismondo MR; Welscher HM; Pfyffer GE
    J Clin Microbiol; 1999 Jan; 37(1):45-8. PubMed ID: 9854062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of mycobacteria growth indicator tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Reisner BS; Gatson AM; Woods GL
    Diagn Microbiol Infect Dis; 1995 Aug; 22(4):325-9. PubMed ID: 8582137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoluciferase Reporter Mycobacteriophage for Sensitive and Rapid Detection of Mycobacterium tuberculosis Drug Susceptibility.
    Jain P; Garing S; Verma D; Saranathan R; Clute-Reinig N; Gadwa J; Peterson C; Hermansky G; Astashkina Fernandez A; Asare E; Weisbrod TR; Spencer E; Mulholland CV; Berney M; Bell D; Nichols KP; Le Ny AM; Ordway D; Jacobs WR; Somoskovi A; Minch KJ
    J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32900827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luciferase reporter phage phAE85 for rapid detection of rifampicin resistance in clinical isolates of Mycobacterium tuberculosis.
    Sivaramakrishnan G; Subramanyam B; C P; Kumar V
    Asian Pac J Trop Med; 2013 Sep; 6(9):728-31. PubMed ID: 23827152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda.
    Traore H; Ogwang S; Mallard K; Joloba ML; Mumbowa F; Narayan K; Kayes S; Jones-Lopez EC; Smith PG; Ellner JJ; Mugerwa RD; Eisenach KD; McNerney R
    Ann Clin Microbiol Antimicrob; 2007 Jan; 6():1. PubMed ID: 17212825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
    Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P
    J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion.
    Tortoli E; Benedetti M; Fontanelli A; Simonetti MT
    J Clin Microbiol; 2002 Feb; 40(2):607-10. PubMed ID: 11825978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the BBL MGIT (Mycobacterial growth indicator tube) AST SIRE system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis to 4 primary antituberculous drugs.
    Bergmann JS; Fish G; Woods GL
    Arch Pathol Lab Med; 2000 Jan; 124(1):82-6. PubMed ID: 10629136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
    El-Sayed Zaki M; Goda T
    Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
    Huang TS; Tu HZ; Lee SS; Huang WK; Liu YC
    Ann Clin Lab Sci; 2002; 32(2):142-7. PubMed ID: 12017195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study.
    Kontos F; Maniati M; Costopoulos C; Gitti Z; Nicolaou S; Petinaki E; Anagnostou S; Tselentis I; Maniatis AN
    J Microbiol Methods; 2004 Feb; 56(2):291-4. PubMed ID: 14744458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa.
    Said HM; Kock MM; Ismail NA; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    BMC Infect Dis; 2012 Dec; 12():369. PubMed ID: 23259765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis.
    Ardito F; Posteraro B; Sanguinetti M; Zanetti S; Fadda G
    J Clin Microbiol; 2001 Dec; 39(12):4440-4. PubMed ID: 11724858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.